Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation

被引:0
作者
Yanagisawa, Ryu [1 ]
Koyama, Hiroaki [2 ]
Yakushijin, Kimikazu [3 ]
Uchida, Naoyuki [4 ]
Jinguji, Atsushi [5 ]
Takeda, Wataru [6 ]
Nishida, Tetsuya [7 ]
Tanaka, Masatsugu [8 ]
Eto, Tetsuya [9 ]
Ohigashi, Hiroyuki [10 ]
Ikegame, Kazuhiro [11 ]
Matsuoka, Ken-ichi [12 ]
Katayama, Yuta [13 ,14 ]
Kanda, Yoshinobu [15 ]
Sawa, Masashi [16 ]
Kawakita, Toshiro [17 ]
Onizuka, Makoto [18 ]
Fukuda, Takahiro [6 ]
Atsuta, Yoshiko [19 ,20 ]
Shinohara, Akihito [2 ]
Nakasone, Hideki [15 ,21 ]
机构
[1] Shinshu Univ Hosp, Div Blood Transfus, Matsumoto, Japan
[2] Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan
[3] Kobe Univ Hosp, Dept Med Oncol & Hematol, Kobe, Japan
[4] Toranomon Gen Hosp, Dept Hematol, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tokyo, Japan
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan
[6] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[7] Nagoya Daiichi Hosp, Japanese Red Cross Aichi Med Ctr, Dept Hematol, Nagoya, Japan
[8] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Japan
[9] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan
[10] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Japan
[11] Hyogo Med Univ Hosp, Dept Hematol, Nishinomiya, Japan
[12] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan
[13] Hiroshima Red Cross Hosp, Dept Hematol, Hiroshima, Japan
[14] Atom Bomb Survivors Hosp, Hiroshima, Japan
[15] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan
[16] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Japan
[17] Natl Hosp Org, Kumamoto Med Ctr, Dept Hematol, Kumamoto, Japan
[18] Tokai Univ, Dept Hematol & Oncol, Sch Med, Isehara, Japan
[19] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagakute, Japan
[20] Aichi Med Univ, Sch Med, Dept Registry Sci Transplant & Cellular Therapy, Nagakute, Japan
[21] Jichi Med Univ, Ctr Mol Med, Div Emerging Med Integrated Therapeut, Shimotsuke, Japan
关键词
CHRONIC KIDNEY-DISEASE; LONG-TERM SURVIVORS; COMORBIDITY INDEX; INJURY; HCT; IMPACT; PATHOGENESIS; DYSFUNCTION; MORTALITY; GVHD;
D O I
10.1038/s41409-023-02172-4
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Various complications can influence hematopoietic cell transplantation (HCT) outcomes. Renal complications can occur during the early to late phases of HCT along with various factors. However, studies focusing on fatal renal complications (FRCs) are scarce. Herein, we analyzed 36,596 first allogeneic HCT recipients retrospectively. Overall, 782 patients died of FRCs at a median of 108 (range, 0-3,440) days after HCT. The cumulative incidence of FRCs was 1.7% and 2.2% at one and five years, respectively. FRCs were associated with older age, male sex, non-complete remission (non-CR), lower performance status (PS), and HCT comorbidity index (HCT-CI) associated with renal comorbidity in multivariate analysis. The risk factors within 100 days included older age, multiple myeloma, PS, and HCT-CI comorbidities (psychiatric disturbance, hepatic disease, obesity, and renal disease). Older age and male sex were risk factors between 100 days and one year. After one year, HCT-CI was associated with the presence of diabetes and prior solid tumor; total body irradiation was identified as a risk factor. Non-CR was a common risk factor in all three phases. Furthermore, acute and chronic graft-versus-host disease, reactivation of cytomegalovirus, and relapse of underlying disease also affected FRCs. Systematic follow-up may be necessary based on the patients' risk factors and post-HCT events.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 50 条
[41]   Prognostic Factors for Mortality among Day+100 Survivors after Allogeneic Hematopoietic Cell Transplantation [J].
Patel, Sagar S. ;
Rybicki, Lisa A. ;
Corrigan, Donna ;
Bolwell, Brian ;
Dean, Robert ;
Liu, Hien ;
Gerds, Aaron T. ;
Hanna, Rabi ;
Hill, Brian ;
Jagadeesh, Deepa ;
Kalaycio, Matt ;
Pohlman, Brad ;
Sobecks, Ronald ;
Majhail, Navneet S. ;
Hamilton, Betty K. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (05) :1029-1034
[42]   Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation [J].
Yoshimitsu, Makoto ;
Tanosaki, Ryuji ;
Kato, Koji ;
Ishida, Takashi ;
Choi, Ilseung ;
Takatsuka, Yoshifusa ;
Fukuda, Takahiro ;
Eto, Tetsuya ;
Hidaka, Michihiro ;
Uchida, Naoyuki ;
Miyamoto, Toshihiro ;
Nakashima, Yasuhiro ;
Moriuchi, Yukiyoshi ;
Nagafuji, Koji ;
Miyazaki, Yasuhiko ;
Ichinohe, Tatsuo ;
Takanashi, Minoko ;
Atsuta, Yoshiko ;
Utsunomiya, Atae .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) :832-839
[43]   Solid cancers after allogeneic hematopoietic cell transplantation [J].
Rizzo, J. Douglas ;
Curtis, Rochelle E. ;
Socie, Gerard ;
Sobocinski, Kathleen A. ;
Gilbert, Ethel ;
Landgren, Ola ;
Travis, Lois B. ;
Travis, William D. ;
Flowers, Mary E. D. ;
Friedman, Debra L. ;
Horowitz, Mary M. ;
Wingard, John R. ;
Deeg, H. Joachim .
BLOOD, 2009, 113 (05) :1175-1183
[44]   Quality of life after allogeneic hematopoietic cell transplantation [J].
Pidala, Joseph ;
Anasetti, Claudio ;
Jim, Heather .
BLOOD, 2009, 114 (01) :7-19
[45]   Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation [J].
de Molla, Vinicius Campos ;
Heidrich, Vitor ;
Bruno, Julia Stephanie ;
Knebel, Franciele Hinterholz ;
Miranda-Silva, Wanessa ;
Asprino, Paula Fontes ;
Tucunduva, Luciana ;
Rocha, Vanderson ;
Novis, Yana ;
Camargo, Anamaria Aranha ;
Fregnani, Eduardo Rodrigues ;
Arrais-Rodrigues, Celso .
SCIENTIFIC REPORTS, 2021, 11 (01)
[46]   Hyperlipidemia and Statin Use after Allogeneic Hematopoietic Stem Cell Transplantation [J].
Blaser, Bradley W. ;
Kim, Haesook T. ;
Alyea, Edwin P., III ;
Ho, Vincent T. ;
Cutler, Corey ;
Armand, Philippe ;
Koreth, John ;
Antin, Joseph H. ;
Plutzky, Jorge ;
Soiffer, Robert J. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (04) :575-583
[47]   Characterization of readmission after allogeneic hematopoietic cell transplantation [J].
Yamaguchi, Kyosuke ;
Inamoto, Yoshihiro ;
Tajima, Kinuko ;
Sakatoku, Kazuki ;
Kuno, Masatomo ;
Kawajiri, Akihisa ;
Takemura, Tomonari ;
Tanaka, Takashi ;
Ito, Ayumu ;
Kurosawa, Saiko ;
Kim, Sung-Won ;
Fukuda, Takahiro .
BONE MARROW TRANSPLANTATION, 2021, 56 (06) :1335-1340
[48]   Lifestyle Factors and Subsequent Ischemic Heart Disease Risk After Hematopoietic Cell Transplantation [J].
Leger, Kasey J. ;
Baker, K. Scott ;
Cushing-Haugen, Kara L. ;
Flowers, Mary E. D. ;
Leisenring, Wendy M. ;
Martin, Paul J. ;
Mendoza, Jason A. ;
Reding, Kerryn W. ;
Syrjala, Karen L. ;
Lee, Stephanie J. ;
Chow, Eric J. .
CANCER, 2018, 124 (07) :1507-1515
[49]   Fatal human metapneumovirus infection following allogeneic hematopoietic stem cell transplantation [J].
Dokos, C. ;
Masjosthusmann, K. ;
Rellensmann, G. ;
Werner, C. ;
Schuler-Luettmann, S. ;
Mueller, K. -M. ;
Schiborr, M. ;
Ehlert, K. ;
Groll, A. H. .
TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (03) :E97-E101
[50]   Impact of a Nutritional Risk Index on Clinical Outcomes after Allogeneic Hematopoietic Cell Transplantation [J].
Sagou, Ken ;
Ozeki, Kazutaka ;
Ukai, Shun ;
Adachi, Yoshitaka ;
Fukushima, Nobuaki ;
Kohno, Akio .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) :2287-2296